by Erica D'Angelo
March 2, 2021
Our partner Diacron has the most comprehensive panel (Panel Carratelli) for global assessment and diagnosis of oxidative balance applicable to many...
by Erica D'Angelo
February 9, 2021
We are excited to introduce to you a silica nanoparticle technology from our partners AcZon. AcZon designed these silica nanoparticles with hopes o...
by Erica D'Angelo
February 8, 2021
Our partner Lena Biosciences has created a novel approach to a 3D Perfused organ-on-a-chip model. In the following paper, they demonstrate how th...
by Erica D'Angelo
February 1, 2021
Whole Genome Bisulfite Sequencing (WGBS) is the gold standard of DNA methylome analysis, but causes DNA fragmentation and damaging, and overestimat...
by Erica D'Angelo
January 27, 2021
AFS Bio has partnered up with Primer Design (A Novacyt Group Company) to support the scientific community's testing efforts.
Primer Design is a...
by Erica D'Angelo
January 21, 2021
AFSBio is excited to introduce the Petaka G3 from Celartia. Today we are showcasing its relevance in supporting biomanufacturing of cell therapies....
by Erica D'Angelo
January 20, 2021
One of AFSBio’s partners, BioGelX, creates hydrogels/supramolecular hydrogels and bioInk for 3D cell culture work. The following paper shows that b...
by Erica D'Angelo
January 19, 2021
AFSBio is proud to announce the beginning of a new distribution agreement with CALIXAR.
Under this agreement, AFSBio will promote and distri...
by Erica D'Angelo
January 14, 2021
At AFSBio, our goal is to help researchers achieve higher quality experimental conditions so they can publish papers of higher relevancy – arriving first at solutions they can publish or patent. With our carefully ...
by Erica D'Angelo
January 14, 2021
AFSBio is proud to partner with Novacyt Group/Primer Design for North America to offer their SaRS-COV-2 (FDA/EUA approved) and SaRS-COV2 Winterplex...
by Erica D'Angelo
January 6, 2021
We are proud to work with AROTEC Diagnostics who are able to supply native autoantigens of consistently high quality, essentially due to the follow...
by Erica D'Angelo
August 14, 2020
We are honoured to have AROTEC join our team at AFSBio! AROTEC are leaders in their field for high performance and exceptionally purified native ...
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
Our partner Diacron has the most comprehensive panel (Panel Carratelli) for global assessment and diagnosis of oxidative balance applicable to many...
We are excited to introduce to you a silica nanoparticle technology from our partners AcZon. AcZon designed these silica nanoparticles with hopes o...
Our partner Lena Biosciences has created a novel approach to a 3D Perfused organ-on-a-chip model. In the following paper, they demonstrate how th...
Whole Genome Bisulfite Sequencing (WGBS) is the gold standard of DNA methylome analysis, but causes DNA fragmentation and damaging, and overestimat...
AFS Bio has partnered up with Primer Design (A Novacyt Group Company) to support the scientific community's testing efforts. Primer Design is a...
AFSBio is excited to introduce the Petaka G3 from Celartia. Today we are showcasing its relevance in supporting biomanufacturing of cell therapies....
One of AFSBio’s partners, BioGelX, creates hydrogels/supramolecular hydrogels and bioInk for 3D cell culture work. The following paper shows that b...
AFSBio is proud to announce the beginning of a new distribution agreement with CALIXAR. Under this agreement, AFSBio will promote and distri...
At AFSBio, our goal is to help researchers achieve higher quality experimental conditions so they can publish papers of higher relevancy – arriving first at solutions they can publish or patent. With our carefully ...
We are honoured to have AROTEC join our team at AFSBio! AROTEC are leaders in their field for high performance and exceptionally purified native ...
